| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5698301 | Clinical Oncology | 2016 | 6 Pages |
Abstract
Before 18 months post-proton therapy, the risk of falsely concluding in favour of a relapse exceeds 5% and should prompt repeat measurements 3 and 6 months later but should not prompt enucleation without further clinical assessment.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
C. Maschi, J. Thariat, J. Herault, J.-P. Caujolle,